Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 126 |
RCOR
126
DELISTED
Renovacor, Inc.
RCOR
| – | – | – | – |
|
| 127 |
RUBY
127
DELISTED
Rubius Therapeutics, Inc
RUBY
| – | – | – | – |
|
| 128 |
SCPS
128
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
| – | – | – | – |
|
| 129 |
SCTX
129
Scribe Therapeutics Inc
SCTX
$392M
| – | – | – | – |
|
| 130 |
SLBT
130
SL Science Holding Ltd
SLBT
$869M
| – | – | – | – |
|
| 131 |
TCRR
131
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – | – | – |
|